Bank Of New York Mellon Corp Adicet Bio, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$1.76 - $3.45 $85,382 - $167,369	48,513 Added 49.74%	146,052 $343 Million
Q4 2023 Jan 29, 2024	SELL	$1.11 - $1.89 $37,577 - $63,984	-33,854 Reduced 25.77%	97,539 $184 Million
Q3 2023 Oct 24, 2023	BUY	$1.37 - $3.4 $41,824 - $103,798	30,529 Added 30.27%	131,393 $180 Million
Q2 2023 Aug 03, 2023	BUY	$2.13 - $7.13 $1,755 - $5,875	824 Added 0.82%	100,864 $245 Million
Q1 2023 May 09, 2023	BUY	$5.52 - $9.23 $552,220 - $923,369	100,040 New	100,040 $576 Million
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $769,629 - $2.12 Million	99,693 New	99,693 $891,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $261,361 - $364,699	19,461 Added 16.92%	134,491 $1.91 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $72,527 - $147,105	-7,069 Reduced 5.79%	115,030 $1.68 Million
Q1 2022 May 11, 2022	BUY	$11.53 - $19.97 $170,632 - $295,536	14,799 Added 13.79%	122,099 $2.44 Million
Q4 2021 Feb 11, 2022	BUY	$7.37 - $17.49 $96,576 - $229,188	13,104 Added 13.91%	107,300 $1.88 Million
Q3 2021 Nov 12, 2021	BUY	$6.29 - $9.93 $45,338 - $71,575	7,208 Added 8.29%	94,196 $737,000
Q2 2021 Aug 11, 2021	BUY	$9.19 - $15.93 $406,060 - $703,867	44,185 Added 103.23%	86,988 $895,000
Q1 2021 May 13, 2021	SELL	$12.12 - $17.17 $521 - $738	-43 Reduced 0.1%	42,803 $559,000
Q4 2020 Feb 09, 2021	BUY	$10.36 - $14.77 $105,630 - $150,594	10,196 Added 31.23%	42,846 $601,000
Q3 2020 Nov 12, 2020	BUY	$10.18 - $21.4 $332,377 - $698,710	32,650 New	32,650 $388,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.